Thelansis

  Plaque psoriasis (PS), also known as psoriasis vulgaris, is the most common form of psoriasis, accounting for 80–90% of cases. The lesions are characteristically well-defined, erythematous, scaly plaques and often have the distribution detailed above (elbows, knees, scalp, inter-gluteal cleft). The plaques vary in size, and patients may present with only a few lesions or with a widely generalized disease. Lesions are often symmetrically distributed. Mild to moderate disease, classified as involving less than 10% of the BSA, represents approximately 80% of cases of plaque psoriasis. The prevalence of psoriasis in the USA ranges from 2.1% to 2.73%, which is slightly higher from a global perspective. Thelansis’s “Plaque Psoriasis (PS) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulator...